These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9334618)

  • 21. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
    Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ
    Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
    Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
    J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.
    Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R
    Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.
    Fowler JE; Bigler SA; Kilambi NK; Land SA
    Urology; 1999 Jun; 53(6):1175-8. PubMed ID: 10367848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate specific antigen as a predictor of an abnormal digital rectal examination.
    Lui PD; Terris MK; Haney DJ; Constantinou CE; Stamey TA
    Br J Urol; 1994 Sep; 74(3):337-40. PubMed ID: 7524998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer early detection practices among men with a family history of disease.
    Bock CH; Peyser PA; Gruber SB; Bonnell SE; Tedesco KL; Cooney KA
    Urology; 2003 Sep; 62(3):470-5. PubMed ID: 12946749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.
    Catalona WJ; Smith DS; Ornstein DK
    JAMA; 1997 May; 277(18):1452-5. PubMed ID: 9145717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men.
    Lam JS; Cheung YK; Benson MC; Goluboff ET
    J Urol; 2003 Aug; 170(2 Pt 1):451-6. PubMed ID: 12853797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model.
    Catalona WJ; Partin AW; Finlay JA; Chan DW; Rittenhouse HG; Wolfert RL; Woodrum DL
    Urology; 1999 Aug; 54(2):220-4. PubMed ID: 10443714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC; Hovey R; Carroll PR; Shinohara K
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of free PSA in early detection of prostate cancer.
    Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
    Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values.
    Crawford ED; Leewansangtong S; Goktas S; Holthaus K; Baier M
    Prostate; 1999 Mar; 38(4):296-302. PubMed ID: 10075009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer screening parameters in a high-risk African-Caribbean population.
    Bunker CH; Patrick AL; Miljkovic-Gacic I; Konety BR; Belle A; Richard JR; Dhir R
    Urology; 2004 Apr; 63(4):737-41. PubMed ID: 15072891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
    Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
    J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.
    Eastham JA; May R; Robertson JL; Sartor O; Kattan MW
    Urology; 1999 Oct; 54(4):709-13. PubMed ID: 10510933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
    Fowler JE; Bigler SA
    Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians.
    Coley CM; Barry MJ; Fleming C; Mulley AG
    Ann Intern Med; 1997 Mar; 126(5):394-406. PubMed ID: 9054286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.
    Thompson IM; Ankerst DP; Chi C; Lucia MS; Goodman PJ; Crowley JJ; Parnes HL; Coltman CA
    JAMA; 2005 Jul; 294(1):66-70. PubMed ID: 15998892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa.
    Heyns CF; Mathee S; Isaacs A; Kharwa A; De Beer PM; Pretorius MA
    BJU Int; 2003 Jun; 91(9):785-8. PubMed ID: 12780832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.